Below are all the acronyms used in the Subscription ebook.
ACCRM | Australian College of Rural and Remote Medicine |
ACON | Aids Council of Australia |
ACR | Urine albumin to creatinine ratio |
ACTH | Adrenocorticotropic hormone |
ADIPS | The Australian Diabetes in Pregnancy Society |
AFP | Alpha feto protein |
AIDS | Acquired Immune Deficiency Syndrome |
AIHW | Australian Institute of Health & Welfare |
AIR | Australian Immunisation Register |
AIS | Adenocarcinoma in situ |
ALCL | Anaplastic large cell lymphoma |
AMBS | Australian Modified Bethesda System |
AMH | Antimüllerian Hormone |
AMS | Australasian Menopause Society |
ANZVS | Australian and New Zealand Vulvovaginal Society |
ARDS | Acute respiratory distress syndrome |
ART | Assisted reproductive technologies |
ASCCP | Australian Society for Colposcopy and Cervical Pathology |
ASHA | Australasian Sexual Health Alliance |
ASHM | Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine |
ASHR1 | First Australian Study of Health and Relationships |
ASHR2 | Second Australian Study of Health and Relationships |
AUB | Abnormal Uterine Bleeding |
AusPATH | The Australian Professional Association for Trans Health |
BASHH | British Association of Sexual Health and HIV |
BBVs | Blood borne viruses |
BIA-ALCL | Breast implant associated-anaplastic large cell lymphoma |
BI-RADS | Breast Imaging Reporting and Data System |
BMD | Bone mineral density |
BMI | Body mass index |
BPH | Benign prostatic hypertrophy |
BRCA1 | Breast cancer 1 |
BRCA2 | Breast cancer 2 |
BV | Bacterial Vaginosis |
CA 19.9 | Cancer antigen 19.9 |
CA 125 | Cancer antigen 125 |
CAD | Coronary artery disease |
CAIS | Complete Androgen Insensitivity Syndrome |
CALD | Culturally and linguistically diverse |
CBT | Cognitive behavioral therapy |
CDC | Centers for Disease Control and Prevention (USA) |
CF | Cystic fibrosis |
cfDNA | Cell free deoxyribonucleic acid |
cFTS | Combined first trimester screening |
CHC | Combined hormonal contraceptive |
CHD | Coronary heart disease |
CIN | Cervical intraepithelial neoplasia |
CMV | Cytomegalovirus |
COC | Combined oral contraceptive |
COCP | Combined oral contraceptive pill |
COPD | Chronic obstructive pulmonary disease |
COPE | The Centre of Perinatal Excellence |
CPC | Child protection services |
CRP | C-reactive protein |
CRS | Congenital rubella syndrome |
CSA | Child Support Agency |
CST | Cervical screening test |
CT | Computerised tomography |
CTG | Closing the Gap |
CV | Cardiovascular disease |
CVS | Chorionic villus sampling |
DAAs | Direct-acting antiviral agents |
DASS | Depression Anxiety Stress Scale |
DBT | Digital breast tomosynthesis |
DCIS | Ductal carcinoma in situ |
DES | Diethylstilboestrol |
DEXA | Dual energy X-ray absorptiometry |
DHEAS | Dehydroepiandrosterone sulfate |
DIE | Deep infiltrating endometriosis |
DMPA | Depo medroxyprogesterone acetate |
DNA | Deoxyribonucleic acid |
DRE | Digital rectal examination |
DSM-V | The Diagnostic and Statistical Manual of Mental Disorders |
DV | Domestic violence |
DVT | Deep vein thrombosis |
ED | Erectile dysfunction |
eGFR | Estimated Glomerular Filtration Rate |
EIA | Enzyme-linked immunoabsorbent assay |
EOGBS | Early-onset group B Streptococcus |
EPAS | Early Pregnancy Assessment Services |
EPDS | Edinburgh Postnatal Depression Scale |
EPG | Protein electrophoresis |
ESR | Erthrocyte sedimentation rate |
EVA | Electric vacuum aspiration |
FACS | Family and Community Services |
FAI | Free androgen index |
FBC | Full blood count |
FBE | Full blood examination |
FDA | Food and Drug Administration |
FGCS | Female genital cosmetic surgery |
FGM | Female genital mutilation |
FGM/C | Female genital mutilation or cutting |
FIFO | Fly-in-fly-out workers |
FIGO | Federation Internationale de Gynecologie et d’Obstetrique |
FME | Forensic medical examination |
FNA | Fine needle aspiration |
FOD | Female orgasmic disorder |
FPU | First pass urine |
FRA-BOC | Familial Risk Assessment – Breast and Ovarian Cancer |
FSH | Follicle stimulating hormone |
FSHR | The UK Faculty of Sexual Health and Reproductive Healthcare |
FSIAD | Female sexual interest and arousal disorder |
FTA-Abs | Fluorescent treponemal antibody absorption test |
FXS | Fragile X syndrome |
GABA | Gamma-aminobutyric acid |
GBS | Group B streptococcus |
GDM | Gestational Diabetes Mellitus |
GnRH | Gonadotrophin-releasing hormone |
GP | General Practitioners |
GTT | Glucose Tolerance Test |
HBeAg | Hepatitis B envelope antigen |
HBcAB | Hepatitis B core antibody |
HbEPG | Haemoglobin electrophoresis |
HBsAg | Hepatitis B surface antigen |
HBV | Hepatitis B Virus |
hCG | Human chorionic gonadotrophins |
HCV | Hepatitis C Virus |
HE4 | Human epididymis protein 4 |
HER2 | Human epidermal growth factor receptor 2 |
HIV | Human immunodeficiency virus |
HMB | Heavy menstrual bleeding |
HNPCC | Hereditary non-polyposis colorectal cancer |
HPLC | High-Performance Liquid Chromatography |
HPO | Human Phenotype Ontology |
HPO | Hypothalamic pituitary ovarian (axis) |
HPV | Human papilloma virus |
HRT | Hormone replacement therapy |
HSDD | Hypoactive sexual desire disorder |
HSIL | High grade squamous intraepithelial lesions |
HSV | Herpes simplex virus |
HT | Hormone therapy |
HVS | High vaginal swab |
ICS | International Continence Society |
ICSI | Intracytoplasmic sperm injection |
IDC | Invasive ductal carcinoma |
IE | Inhibited ejaculation |
IELT | Intravaginal ejaculation latency time |
IGF-1 | Insulin-like growth factor 1 |
IIEF5 | International Index of Erectile Dysfunction |
ILC | Invasive lobular carcinoma |
IMB | Intermenstrual bleeding |
IOTA | International Ovarian Tumour Analysis |
IPV | Intimate partner violence |
ISD | Intrinsic Sphincter Deficiency |
ISSM | International Society for Sexual Medicine |
ISSVD | International Society for the Study of Vulvovaginal Disease |
ITP | Idiopathic thrombocytopenic purpura |
IUD | Intrauterine device |
IUI | Intrauterine insemimation |
IUP | Intrauterine pregnancy |
IV | Intravenous |
IVF | In vitro fertilisation |
IVP | Intravenous pyelogram |
K10 | Kessler Psychological Distress Scale |
KUB | Kidney, ureters and bladder |
LAM | Lactational Amenorrhoea Method |
LBC | Liquid-based cytology |
LCIS | Lobular carcinoma in situ |
LEEP | Loop electrosurgical excision procedure |
LFT | Liver function tests |
LGBTQI | Lesbian, Gay, Bisexual, Transgender, Queer or Questioning, and Intersex |
LGV | Lymphogranuloma venereum |
LH | Luteinizing Hormone |
LH/FSH | Luteinising Hormone/Follicle Stimulating Hormone |
LLETZ | Large loop excision of the transformation zone |
LMP | Last menstrual period |
LNG | Levonorgestrel |
LOH | Late onset hypogonadism |
LPU | Last pass urine |
LSIL | Low grade squamous intraepithelial lesion |
LUTS | Lower urinary tract symptoms |
MAO | Monoamine oxidase inhibitors |
MBS | Medicare Benefits Schedule |
MCS | Urine microscopy, culture and sensitivity |
MCV | Mean corpuscular volume |
MG | Mycoplasma genitalium |
MHAHS | Multicultural HIV and Hepatitis Service |
MHT | Menopausal Hormone Therapy |
MMR | Measles mumps rubella |
MRI | Magnetic resonance imaging |
MRKH | Mayer-Rokitansky-Kuster-Hauser Syndrome |
MS | Multiple sclerosis |
MSHC | Melbourne Sexual Health Centre |
MSM | Men who have sex with men |
MSU | Midstream urine |
MTOP | Medical termination of pregnancy |
MVA | Manual vacuum aspiration |
NAAT | Nucleic acid amplification test |
NCSP | National Cervical Screening Program |
NCSR | National Cancer Screening Register |
NGU | Non-gonococcal urethritis |
NHMRC | National Health and Medical Research Council |
NICE | The National Institute for Health and Care Excellence |
NNDSS | The National Notifiable Diseases Surveillance System |
NPV | Negative predictive value |
NRT | Nicotine replacement therapy |
NSAIDs | Nonsteroidal anti-inflammatory drugs |
NSQHS | National Safety and Quality Health Service Standards |
NSU | Nonspecific urethritis |
NTD | Neural tube defect |
OAB | Overactive bladder |
OCP | Oral Contraceptive Pill |
OHSS | Ovarian Hyperstimulation Syndrome |
OSA | Obstructive sleep apnea |
PADAM | Partial androgen deficiency of the ageing male |
PALM-COEIN | Polyp; adenomyosis; leiomyoma; malignancy and hyperplasia; coagulopathy; ovulatory dysfunction; endometrial; iatrogenic; and not yet classified |
PAOD | Peripheral arterial occlusive disease |
PAPP-A | Pregnancy-associated plasma protein-A |
PAS | Pregnancy advisory service |
PBMG | Pregnancy and Breastfeeding Medicines Guide |
PBS | Pharmaceutical Benefits Scheme |
PCB | Post coital bleeding |
PCO | Polycystic ovaries |
PCOM | Polycystic ovary morphology |
PCOS | Polycystic ovary syndrome |
PCR | Polymerase chain reaction |
PDE 5 | Phosphodiesterase-5 (inhibitors) |
PDPT | Patient delivered partner therapy |
PE | Premature ejaculation |
PEACH | PID Evaluation and Clinical Health |
PEP | Post-exposure prophylaxis |
PET | Preterm pre-eclampsia |
PGE1 | Prostaglandin E1 |
pHSIL | Possible high-grade squamous intraepithelial lesion |
PID | Pelvic Inflammatory Disease |
PIGF | Placental growth factor |
PKU | Phenylketonuria |
PMB | Postmenopausal bleeding |
PMDD | Premenstrual dysphoric disorder |
PMF | Pelvic floor muscle |
PMFT | Pelvic floor muscle training |
PMS | Premenstrual syndrome |
PO | Per os (by mouth) |
POC | Products of conception |
POI | Premature ovarian insufficiency |
POP | Pelvic organ prolapse |
POP | Progestogen-only pill |
POPQ | Pelvic organ prolapse quantification |
PPV | Positive predictive value |
PrEP | Pre-exposure prophylaxis |
PSA | Prostate specific antigen |
QoL | Quality of life |
RACGP | Royal Australian College of General Practitioners |
RANZCOG | The Royal Australian and New Zealand College of Obstetricians and Gynaecologists |
RCOG | Royal College of Obstetricians and Gynaecologists |
RCT | Randomised controlled trial |
REM | Rapid eye movement |
RMI | Risk of Malignancy Index |
RNA | Ribonucleic acid |
ROMA | Risk of malignancy algorithm |
RPOC | Retained products of conception |
RPR | Rapid plasma reagin |
RSH | Reproductive and sexual health |
SHBG | Sex hormone binding globulin |
SHIM | Sexual Health Inventory for Men |
SERM | Selective oestrogen receptor modulator |
SLE | Systemic Lupus Erythematous |
SMA | Spinal muscular atrophy |
SNRI | Serotonin and noradrenaline reuptake inhibitors |
SSRI | Selective serotonin reuptake inhibitor |
STARTTS | The Service for Treatment and Rehabilitation of Trauma and Torture Survivors |
STEAR | Selective tissue estrogenic activity regulator |
STIGMA | Sexually Transmissible Infections in Gay Men Action Group |
STIPU | Sexually Transmissible Infections Programs Unit (NSW) |
STIs | Sexually transmissible infections |
STOP | Surgical termination of abortion |
SUI | Stress urinary incontinence |
SVR | Sustained viral response |
SWAN | Study of Women’s Health Across the Nation |
TCAs | Tricyclic antidepressants |
TDLUs | Terminal duct lobular unit |
TFT | Thyroid function tests |
TGA | Therapeutic Goods Administration |
TGD | Trans and gender diverse |
TIS | Translating and Interpreting Service |
TOP | Termination of pregnancy |
TORCH | Toxoplasmosis; Other – syphilis, varicella, mumps, parvovirus and human immunodeficiency virus, listeriosis; Rubella; Cytomegalovirus; and Herpes |
TPHA | Treponema pallidum haemagglutination |
TPPA | Treponema pallidum particle agglutination |
TRT | Testosterone replacement therapy |
TSH | Thyroid stimulating hormone |
TSEC | Tissue selective oestrogen complex |
TSS | Toxic shock syndrome |
TUIP | Transurethral incision of the prostate |
TURP | Transurethral resection of the prostate |
TV | Trichomonas vaginalis |
TVS | Transvaginal sonography |
TVUS | Transvaginal ultrasound |
UAE | Uterine artery embolisation |
UEC | Urea, electrolytes and creatinine |
UKMEC | UK Medical Eligibility Criteria |
UTI | Urinary tract infection |
UUI | Urge urinary incontinence |
VAN | Violence Abuse and Neglect (services) |
VDRL | Venereal disease reference laboratory |
VMS | Vasomotor symptoms |
VTE | Venous thromboembolic event |
VZV | Varicella-zoster vaccine |
WHO | World Health Organization |
Chapters
- Chapter 1 – Reproductive and Sexual Health Consultations in the Australian Setting
- Chapter 2 – The Cervix
- Chapter 3 – The Ovary
- Chapter 4 – The Vagina and Vulva
- Chapter 5 – The Breast
- Chapter 6 – The Bladder and the Pelvic Floor
- Chapter 7 – Abnormal Uterine Bleeding and Other Disorders of the Menstrual Cycle
- Chapter 8 – Fertility Problems
- Chapter 9 – Preconception Care and Pregnancy
- Chapter 10 – Pregnancy Options
- Chapter 11 – Menopause
- Chapter 12 – Sexually Transmissible Infections (STIs)
- Chapter 13 – Pelvic Inflammatory Disease (PID)
- Chapter 14 – Acute Pelvic Pain and Other Gynaecological Emergencies
- Chapter 15 – Reproductive and Sexual Health for Trans and Gender Diverse People
- Chapter 16 – Management of Sexual Assault and Domestic Violence in Primary Health Care
- Chapter 17 – Female Sexual Interest and Arousal Disorder (FSIAD)
- Chapter 18 – Male Sexual Dysfunction, Prostate Disease and Testicular Lumps
- Chapter 19 – Legal Considerations in Reproductive and Sexual Health